Ozempic users say their exes are attempting to reconnect with them after weight loss: ‘Second chance…
Category: GLP-1 News
Vori Health secures $53m funding to support musculoskeletal care
Vori Health has secured $53m in a Series B funding round, supporting its value-based musculoskeletal care…
Understanding GLP-1: The Key to Managing Blood Sugar
Glucagon-like peptide-1 (GLP-1) is a hormone that plays a crucial role in glucose metabolism and appetite…
Unlocking the Potential of GLP-1 for Improved Health
Glucagon-like peptide-1 (GLP-1) is a hormone that plays a crucial role in glucose metabolism and appetite…
Roche Inks ‘The Largest Obesity Deal To Date’ With Zealand Pharma At $5.3 Billion – Investor’s Business Daily
Roche Inks ‘The Largest Obesity Deal To Date’ With Zealand Pharma At $5.3 Billion Investor’s Business Daily
Roche Targets Weight-Loss Drug Market Dominated by Novo Nordisk, Eli Lilly – Investopedia
Roche Targets Weight-Loss Drug Market Dominated by Novo Nordisk, Eli Lilly Investopedia
Roche Further Boosts Obesity Pipeline With Zealand Pharma Deal Worth $5.3 Billion For Weight Loss Drugs – Benzinga
Roche Further Boosts Obesity Pipeline With Zealand Pharma Deal Worth $5.3 Billion For Weight Loss Drugs Benzinga
What are the other health benefits weight-loss drugs may offer? – TODAY
What are the other health benefits weight-loss drugs may offer? TODAY
How weight-loss drugs could help treat addiction, arthritis, more – TODAY
How weight-loss drugs could help treat addiction, arthritis, more TODAY
Novo Nordisk, Lilly Stocks Are Falling. A Rival Weight-Loss Drug Is on the Way. – Barron’s
Novo Nordisk, Lilly Stocks Are Falling. A Rival Weight-Loss Drug Is on the Way. Barron’s